Tema Oncology ETF (NASDAQ:CANC) Holdings Increased by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans increased its stake in Tema Oncology ETF (NASDAQ:CANC) by 29.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 517,837 shares of the company’s stock after acquiring an additional 118,328 shares during the period. Thrivent Financial for Lutherans owned approximately 0.20% of Tema Oncology ETF worth $13,156,000 at the end of the most recent reporting period.

Tema Oncology ETF Trading Down 0.8 %

Shares of Tema Oncology ETF stock opened at $24.95 on Friday. Tema Oncology ETF has a 52 week low of $23.97 and a 52 week high of $30.11. The company’s 50-day moving average price is $25.25 and its two-hundred day moving average price is $26.57. The stock has a market cap of $63.62 million, a PE ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.